COVID-19 vaccines are now transitioning to the development of booster shots, with Pfizer and BioNTech, and Moderna CEOs discuss the immediacy of its need by year's end and delivering it by September. The booster is to help the immunization response of a person to improve its protection against the coronavirus to end its infection.

French Firefighters Receive Pfizer BioNTech Covid-19 Vaccine
(Photo : Arnold Jerocki/Getty Images)
French Firefighters Receive Pfizer BioNTech Covid-19 Vaccine AVIGNON, FRANCE - JANUARY 08: A firefighter receives a Pfizer BioNTech Covid-19 vaccine on January 8, 2021 in Avignon, France. After the government's announcement that health workers are a priority for the vaccine, French firefighters over 50 will receive the Covid-19 vaccine. With a slow start to the vaccination campaign, the French government is committed to a rapid ramp-up.

The development of COVID-19 vaccines was one of the fastest immunization processes in the world, especially as it showed how technology has helped in fast-tracking its development. Currently, mRNA vaccines are leading the world with Pfizer and Moderna's vaccine which has the least adverse health effects, with high rates of protection. 

Vaccines cannot guarantee full protection or the so-called "perfect" 100 percent immunity rate against COVID-19 or any other diseases or viruses, but it sure helps out to ready people in the body's defense. With the many vaccines available against COVID now, people have even considered mixing and matching these to get the "optimal" results, which is not recommended. 

Read Also: Google Maps Encourages Android Users by Replacing the Usual Search Pin with Search for COVID-19 Vaccine

COVID-19 Vaccine Boosters by September

COVID-19 Vaccine
(Photo : Pexels/RF._.studio)
covid-19 vaccine effective against new mutation

For Americans or other nationalities who have received COVID-19 vaccines as early as December 2020 and January 2021, the need for a booster shot is recommended by September or October this year. Pfizer and Moderna CEO have openly discussed this, saying that boosters are needed as early as seven to eight months after the first completion. 

According to Axios, this was openly discussed by both of the pharmaceutical companies' CEOs, particularly with Pfizer's Albert Bourla which has initially insisted on its need at least 12 months after

On the other hand, the US Center for Disease and Control Prevention (CDC) has not discussed any booster requirements after completing the two doses from different companies' vaccines. This includes those which have been approved for emergency use authorization (EUA), by the US Food and Drug Administration (FDA). 

Boosters Are Coming by Year's End, Following the Near Completion of Vaccination

CDC has tallied the statistics of the vaccinated population of the country and as of Thursday, May 20, the country has already fully vaccinated 38.1 percent of its population, and 48.2 percent with at least one dose. 

Boosters are not yet recommended by the CDC, but the pharma companies are aiming for its delivery by September towards the end of the year. 

Related Article: COVID-19 Vaccine Effectivity: Not That High with 'Immunocompromised' People, Transplant Recipients, Says Study


This article is owned by Tech Times


Written by Isaiah Richard

ⓒ 2021 TECHTIMES.com All rights reserved. Do not reproduce without permission.